Xiaohong Yang Selected Research

albomycin

1/2018

Total synthesis and antimicrobial evaluation of natural albomycins against clinical pathogens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohong Yang Research Topics

Disease

31	Neoplasms (Cancer) 05/2022 - 09/2012
18	Infections 04/2022 - 08/2010
14	Inflammation (Inflammations) 10/2021 - 05/2013
12	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2017
6	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 01/2019
6	Coronary Artery Disease (Coronary Atherosclerosis) 03/2022 - 02/2015
5	Bone Resorption 11/2015 - 01/2011
4	Stroke (Strokes) 03/2022 - 04/2015
4	Obesity 03/2022 - 02/2020
4	Fibrosis (Cirrhosis) 10/2021 - 06/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 05/2013
4	Hypoxia (Hypoxemia) 12/2020 - 10/2016
4	Lung Neoplasms (Lung Cancer) 12/2020 - 09/2018
4	Alzheimer Disease (Alzheimer's Disease) 09/2020 - 02/2015
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 09/2015
4	Carcinogenesis 11/2019 - 01/2016
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2020
3	Macular Edema 05/2021 - 12/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2020
3	COVID-19 01/2021 - 01/2020
3	Hypertension (High Blood Pressure) 01/2020 - 01/2016
3	Osteoporosis 12/2019 - 09/2011
3	IGA Glomerulonephritis (IGA Nephropathy) 09/2019 - 09/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2017
3	Osteolysis 11/2015 - 09/2011
3	Atherosclerosis 01/2014 - 05/2013
2	Macular Degeneration (Age-Related Maculopathy) 09/2022 - 10/2019
2	Babesiosis (Piroplasmosis) 03/2022 - 01/2021
2	Parkinson Disease (Parkinson's Disease) 03/2022 - 01/2022
2	Chronic Disease (Chronic Diseases) 03/2022 - 01/2022
2	Disease Progression 01/2022 - 06/2018
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2015
2	Encephalitis (Encephalitis, Rasmussen) 02/2021 - 02/2011
2	Bird Fancier's Lung 01/2021 - 02/2017
2	Ganglion Cysts (Ganglion) 01/2021 - 01/2020
2	Insulin Resistance 01/2021 - 11/2020
2	Congenital Heart Defects (Congenital Heart Defect) 01/2021 - 12/2020
2	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 12/2019
2	Pathologic Processes 09/2020 - 01/2019
2	Neuroinflammatory Diseases 09/2020 - 07/2017
2	Eye Diseases (Eye Disease) 09/2020 - 02/2019
2	Contagious Ecthyma 01/2020 - 01/2019
2	Death (Near-Death Experience) 01/2020 - 09/2015

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 04/2022 - 11/2014
14	Pharmaceutical PreparationsIBA 05/2022 - 08/2010
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2013
11	Retinaldehyde (Retinal)IBA 03/2022 - 01/2020
10	1-penicillamyl-Leu(2)- oxytocinIBA 01/2022 - 05/2013
9	Apolipoproteins B (ApoB)IBA 01/2022 - 05/2013
9	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 05/2013
7	Lipoprotein(a)IBA 03/2021 - 05/2013
7	Messenger RNA (mRNA)IBA 02/2021 - 02/2011
6	Biological ProductsIBA 02/2021 - 05/2016
5	Apolipoprotein B-100 (Apo B 100)IBA 01/2022 - 04/2015
5	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2019
5	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 01/2020
5	CytokinesIBA 01/2021 - 01/2011
4	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 03/2022 - 01/2021
4	pyrotinibIBA 01/2022 - 01/2020
4	Phosphotransferases (Kinase)IBA 03/2021 - 04/2017
4	Antiviral Agents (Antivirals)IBA 02/2021 - 01/2011
4	CalciumIBA 10/2020 - 01/2014
4	Interleukin-6 (Interleukin 6)IBA 09/2018 - 01/2011
3	CholesterolIBA 03/2022 - 01/2017
3	SteroidsIBA 01/2022 - 01/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 01/2018
3	InterferonsIBA 01/2021 - 01/2011
3	EpitopesIBA 01/2021 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2019
3	Long Noncoding RNAIBA 10/2020 - 01/2016
3	VaccinesIBA 01/2020 - 01/2011
3	casticinIBA 09/2018 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2017 - 11/2014
3	Atorvastatin (Lipitor)FDA Link 01/2017 - 01/2014
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 01/2014
3	Lipoproteins (Lipoprotein)IBA 01/2017 - 05/2013
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2013 - 01/2011
2	Oxidoreductases (Dehydrogenase)IBA 03/2022 - 03/2021
2	trioctyl phosphine oxide (TOPO)IBA 01/2022 - 02/2019
2	Triglycerides (Triacylglycerol)IBA 10/2021 - 01/2017
2	Nucleic AcidsIBA 01/2021 - 09/2020
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2020
2	Caspase 3 (Caspase-3)IBA 11/2020 - 09/2018
2	GlucocorticoidsIBA 09/2020 - 12/2019
2	LipopolysaccharidesIBA 09/2020 - 07/2017
2	Therapeutic UsesIBA 09/2020 - 02/2019
2	LipidsIBA 02/2020 - 05/2013
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2020
2	Apolipoprotein C-IIIIBA 01/2020 - 01/2017
2	Circulating Tumor DNAIBA 01/2020 - 06/2018
2	Ranibizumab (Lucentis)FDA Link 01/2020 - 12/2019
2	ferulic acid (sodium ferulate)IBA 12/2019 - 01/2017
2	Phenobarbital (Luminal)FDA Link 11/2019 - 01/2019
2	Oxygen (Dioxygen)IBA 09/2019 - 07/2017
2	3' Untranslated Regions (3' UTR)IBA 09/2019 - 06/2019

Therapy/Procedure

17	Therapeutics 03/2022 - 08/2010
3	Drug Therapy (Chemotherapy) 05/2022 - 02/2007
2	Aftercare (After-Treatment) 05/2022 - 06/2018
2	Radiotherapy 01/2022 - 01/2020
2	Microspheres (Microsphere) 01/2021 - 12/2020